StockData

Grail vs Personalis

GRAL and PSNL side by side, both in health services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How GRAL and PSNL compare

Grail is the larger company, worth 3.0 times as much as Personalis ($4.7B against $1.6B).

Grail grew revenue faster over the last twelve months (23.1% versus −13.3% for Personalis).

Personalis keeps more of each dollar of sales as profit, with a net margin of −154% compared with −237% at Grail.

Grail scores higher on the StockData Score (10 against 5 for Personalis), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricGRALPSNL
Size and price
Market cap$4.7B$1.6B
Share price$105.60$14.80
Change, 1 year26.9%94.7%
Change, 5 years–5.8%
Beta (5Y)2.061.24
Employees910260
StockData Score
Total score10 (better)5
Valuation score1 (better)0
Growth score2 (better)0
Performance score1 (better)0
Health score6 (better)5
Dividend score00
Valuation
P/S28.5×22.7× (better)
P/B1.9× (better)6.7×
FCF yield−6.3% (better)−6.4%
Fair value–$3.33
Margin of safety–−344%
Growth
Revenue growth (TTM)23.1% (better)−13.3%
Revenue growth, 5Y average–−2.4%
Profitability
Gross margin–12.7%
Operating margin−338%−164% (better)
Net margin−237%−154% (better)
FCF margin−179%−145% (better)
Return on equity−16.1% (better)−50.3%
Return on invested capital−26.0% (better)−450%
Financial health
Debt / equity0.000.00
Interest coverage–−536.7×
Current ratio10.95 (better)5.28
Altman Z-score4.038.99 (better)
Piotroski F-score5 (better)4
Dividends and buybacks
Buyback yield–−8.5%
Shareholder yield0.00% (better)−8.5%
Ownership
Held by institutions87.6%79.6%
Held by insiders11.0%15.0%
Insider net buying, 12 months−$38.0M−$6.9M (better)
Short interest, % of float20.1%7.4%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.